Opinions
Lou Schizas
Cardiocomm Solutions
EKG-X
DON'T BUY
Jun 17, 2003
Very thinly traded. Speculative. Has had 10 quarters of losses. FDA approval didn't move the stock.
$0.155
Stock price when the opinion was issued
medical services
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.